Differential effects of inhibition of interleukin 1 and 6 on myocardial, coronary and vascular function

Volume: 108, Issue: 10, Pages: 1093 - 1101
Published: Mar 11, 2019
Abstract
Anakinra, an interleukin-1 receptor antagonist and tocilizumab, an interleukin-6 receptor blocker, are used for the treatment of rheumatoid arthritis. We investigated the differential effects of anakinra and tocilizumab on myocardial and vascular function in an atherosclerosis model of patients with rheumatoid arthritis. 120 patients with rheumatoid arthritis were randomized to anakinra (n = 40), tocilizumab (n = 40) or prednisolone (n = 40) for...
Paper Details
Title
Differential effects of inhibition of interleukin 1 and 6 on myocardial, coronary and vascular function
Published Date
Mar 11, 2019
Volume
108
Issue
10
Pages
1093 - 1101
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.